英发现FPG是预测高血压患者新发糖尿病的最佳指标

英发现FPG是预测高血压患者新发糖尿病的最佳指标
 
根据一项大型临床试验亚组资料分析显示，空腹血浆葡萄糖(FPG)是高血压患者是预测高血压患者新发糖尿病最好的预测因子。

对盎格鲁-斯堪的纳维亚人心脏预后临床试验-降低血压分部(ASCOT-BPLA)期间患上糖尿病患者的资料分析，研究人员制定出了危险评分，区分在抗高血压治疗期间新发糖尿病(NOD)危险性最高的患者。在2006年9月西班牙巴塞罗那举行的2006世界心脏病学大会上，由来自英国伦敦帝国大学的Ajay K. Gupta医学博士进行了报道。

Glucose Best Predicts Diabetes in Hypertension Patients
 
Fasting plasma glucose (FPG) may be the best predictor of risk of new-onset diabetes in hypertension patients, according to a subgroup analysis of data from a major trial.

Analysis of patients who developed diabetes during the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) has allowed investigators to create a risk score that appears to discriminate those at highest risk for development of new-onset diabetes (NOD) during antihypertensive therapy. The analysis was presented in September 2006 in Barcelona (Spain) at the World Congress of Cardiology 2006 by Ajay K. Gupta, M.D., from Imperial College London (UK).